AbbVie had been working with Reata on the Nrf2 programme since 2010 when it ... in the US after the drug failed studies in chronic kidney disease and diabetic kidney disease.
In diabetic kidney disease, fat accumulates in the kidneys, leading to lipotoxicity and kidney damage. A recently published ...